Bovine tuberculosis is a chronic infectious disease of cattle and other mammals caused mainly by *Mycobacterium bovis*. It typically produces slowly developing inflammatory lesions in the lungs and lymph nodes, although many infected animals show no obvious signs. The disease affects livestock production, animal trade, wildlife management, and public health because its causative bacteria can also infect humans. Human infection acquired from animals is a form of zoonosis and causes tuberculosis.
Causative organisms and host range
M. bovis belongs to the *Mycobacterium tuberculosis* complex, a group of closely related bacteria that cause tuberculosis in humans and animals. Mycobacterium caprae, another member of this complex, also causes tuberculosis in cattle and other mammals, particularly in parts of Europe. Bovine tuberculosis is therefore not exclusively associated with a single bacterial species, although M. bovis is its principal cause worldwide.
Cattle are major hosts, but M. bovis has a broad mammalian host range. Infection occurs in buffalo, deer, badgers, wild boar, goats, camelids, and various captive and free-ranging mammals. The epidemiological importance of each host varies by setting.
A distinction is made between maintenance hosts, whose populations can sustain infection without repeated introduction from another species, and spillover hosts, which acquire infection but do not ordinarily maintain it independently. Host status depends on population density, behaviour, environmental conditions, and contact networks, rather than species identity alone.
Transmission
Among cattle, transmission commonly occurs through inhalation of infectious droplets or aerosols during close contact. Infected animals may shed bacteria in respiratory secretions and, depending on the organs involved, in milk or other bodily materials. Ingestion is another route, particularly when calves consume infected milk.
Movement of infected cattle can introduce the disease into previously unaffected herds. Shared housing, prolonged contact, and interactions at feeding or watering sites can facilitate transmission. Contaminated environments may also contribute, although the relative importance of direct and indirect transmission differs between production systems.
Humans can acquire M. bovis through consumption of unpasteurized milk or dairy products made from infected milk. Occupational exposure may occur through inhalation or contact with infected animals and tissues, including during farming, veterinary work, and slaughter. Human-to-human transmission is possible but is less commonly documented than transmission of human tuberculosis caused by M. tuberculosis.
Disease development and clinical signs
After entering the host, the bacteria can survive within macrophages, immune cells that normally engulf and destroy microorganisms. The host response may contain infection without eliminating it.
A characteristic lesion is the granuloma, an organized collection of immune cells that forms around persistent infection. Tuberculous granulomas may develop central, cheese-like tissue death, known as caseous necrosis, and may later become mineralized. Lesions frequently involve the lungs and associated lymph nodes. Infection acquired through ingestion may involve lymph nodes associated with the digestive tract.
Disease progression is variable. Some animals remain infected without visible clinical illness for long periods; others develop progressive or disseminated disease. Advanced signs can include:
- Gradual weight loss and poor body condition.
- Persistent cough or breathing difficulty.
- Enlarged superficial lymph nodes.
- Reduced milk production.
- Weakness and intermittent fever.
These findings are not specific to bovine tuberculosis. The absence of clinical signs does not exclude infection, and visibly healthy cattle can be detected through testing or slaughterhouse inspection.
Diagnosis and surveillance
Control programmes combine herd testing, animal-movement records, slaughterhouse inspection, and laboratory investigation. No single test detects every infected animal under all conditions.
Tests in living animals
The tuberculin skin test measures a delayed immune reaction to injected mycobacterial proteins. Skin thickness is measured before injection and again after a specified interval, commonly about 72 hours. Comparative tests use both bovine and avian tuberculin to help distinguish responses associated with tuberculosis from sensitization to other environmental mycobacteria.
The interferon-gamma release assay measures a cellular immune response in a blood sample stimulated with mycobacterial antigens. It may supplement skin testing, depending on the control programme. Antibody tests have additional uses in some species and circumstances but do not universally replace cellular immune tests.
Diagnostic sensitivity and specificity depend on the test, interpretation threshold, stage of infection, and population tested. Recent infection, advanced disease, and other biological factors can affect responses. A positive screening result is therefore interpreted within an epidemiological and regulatory framework.
Post-mortem and laboratory investigation
Slaughterhouse examination can identify suspicious lesions in animals that were not recognized as infected during life. Laboratory investigation may include:
- Histopathology to assess characteristic tissue changes.
- Microscopy with acid-fast staining.
- Bacterial culture and identification.
- Polymerase chain reaction to detect bacterial genetic material.
Culture provides evidence of viable organisms but can take several weeks because the bacteria grow slowly. Molecular identification distinguishes members of the tuberculosis complex. DNA sequencing, including whole-genome sequencing, can help investigate relationships among cases, although genetic similarity alone does not establish the direction or precise route of transmission.
Distribution and wildlife reservoirs
Bovine tuberculosis occurs in many regions, but its distribution is uneven. Sustained testing and removal programmes have eliminated it from domestic cattle populations in some countries or substantially reduced its occurrence. Elsewhere, limited testing, livestock movements, and wildlife reservoirs complicate control.
Well-established wildlife-associated systems include European badgers in parts of Britain and Ireland, brushtail possums in New Zealand, white-tailed deer in parts of the United States, and African buffalo in some southern African ecosystems. These examples do not mean that every population of these species maintains infection.
Wildlife and livestock can participate in connected transmission networks. Their relative contributions must be established locally through epidemiological investigation rather than inferred simply from finding infected wildlife near an affected herd.
Prevention and control
Livestock control programmes commonly use repeated testing, removal of animals classified as infected or reactors under programme rules, movement restrictions, contact tracing, and inspection at slaughter. Herd accreditation and compensation arrangements may support implementation.
Biosecurity measures address pathways by which infection enters or spreads within herds, including animal introductions and contact with infected livestock or wildlife. Food-safety controls include pasteurization of milk and veterinary inspection of animal products. The combination of cattle control and milk pasteurization has greatly reduced human M. bovis infection in many settings.
Antibiotic treatment is generally not used as a herd-control strategy in cattle. Its prolonged duration, difficulties confirming elimination of infection, food-residue concerns, and regulatory requirements favour removal-based control in many programmes.
The BCG vaccine, derived from an attenuated strain of M. bovis, has been studied and used in some animal settings. Vaccination does not provide complete protection and can complicate interpretation of conventional tuberculin testing. Tests designed to differentiate infected from vaccinated animals are consequently important to cattle-vaccination strategies.
Human health significance
Human disease caused by M. bovis can affect the lungs or other organs, including lymph nodes, bones, and the digestive tract. Its clinical appearance cannot reliably distinguish it from tuberculosis caused by M. tuberculosis; species identification requires laboratory methods.
An important treatment-related distinction is that M. bovis is intrinsically resistant to pyrazinamide, a drug commonly included in initial treatment for drug-susceptible human tuberculosis. Laboratory identification therefore has clinical as well as epidemiological significance.
Control is often framed through One Health, which connects animal, human, and environmental health. Veterinary surveillance, food safety, human tuberculosis services, and wildlife investigation provide complementary information. The contribution of M. bovis to human tuberculosis remains incompletely measured in settings where routine laboratory testing does not distinguish organisms within the tuberculosis complex.